Improvement of mortality by long-term E4010 treatment in monocrotaline-induced pulmonary hypertensive rats - PubMed (original) (raw)
. 1999 Aug;290(2):748-52.
Affiliations
- PMID: 10411587
Improvement of mortality by long-term E4010 treatment in monocrotaline-induced pulmonary hypertensive rats
K Kodama et al. J Pharmacol Exp Ther. 1999 Aug.
Abstract
We investigated the effects of long-term treatment with a selective phosphodiesterase 5 inhibitor E4010, 4-(3-chloro-4methoxybenzyl)amino-1-(4-hydroxypiperidino)-6-phth alazin ecarbonitrile monohydrochloride, on the survival rate of rats with pulmonary hypertension induced by monocrotaline (MCT). After an s.c. injection of 40 mg/kg MCT (day 0), male Wistar rats of 4 weeks of age were divided into four groups. Vehicle-treated rats (control, n = 8) and MCT-treated rats (n = 32) were fed a commercial diet. E4010-treated rats were given a commercial diet containing 0.01% (E4010 0.01%, n = 32) and 0.1% (E4010 0.1%, n = 32) of E4010, respectively. At day 23, all rats in the control group and 28.1% of those in the MCT group (P <.01 versus control) were alive. Although the survival rate of E4010 0.01%-treated rats was not improved (50%) compared with MCT, those at 0.1% showed a significant difference (84. 4%, P <.01 versus MCT). For MCT rats (n = 9), right ventricle weight and the levels of plasma atrial natriuretic peptide (ANP), brain natriuretic peptide (BNP), cGMP, and cyclic AMP were higher compared with control (n = 8). In E4010 0.1%-treated rats (n = 27), the right ventricular hypertrophy was suppressed, and the increase in plasma cGMP level was amplified compared with MCT without any effects on plasma ANP, BNP, and cyclic AMP levels. Accordingly, we consider that the mechanism of action of E4010 may be related to the decreased pulmonary arterial pressure caused by the augmentation of pulmonary arterial relaxation through an ANP and/or BNP-cGMP system. These results suggest that E4010 will be useful for the treatment of pulmonary hypertension.
Similar articles
- DA-8159, a potent cGMP phosphodiesterase inhibitor, attenuates monocrotaline-induced pulmonary hypertension in rats.
Kang KK, Ahn GJ, Sohn YS, Ahn BO, Kim WB. Kang KK, et al. Arch Pharm Res. 2003 Aug;26(8):612-9. doi: 10.1007/BF02976710. Arch Pharm Res. 2003. PMID: 12967196 - Chronic inhibition of phosphodiesterase 5 does not prevent pressure-overload-induced right-ventricular remodelling.
Schäfer S, Ellinghaus P, Janssen W, Kramer F, Lustig K, Milting H, Kast R, Klein M. Schäfer S, et al. Cardiovasc Res. 2009 Apr 1;82(1):30-9. doi: 10.1093/cvr/cvp002. Epub 2009 Jan 8. Cardiovasc Res. 2009. PMID: 19131365 - Genistein, a phytoestrogen, attenuates monocrotaline-induced pulmonary hypertension.
Homma N, Morio Y, Takahashi H, Yamamoto A, Suzuki T, Sato K, Muramatsu M, Fukuchi Y. Homma N, et al. Respiration. 2006;73(1):105-12. doi: 10.1159/000088946. Epub 2005 Oct 1. Respiration. 2006. PMID: 16432296 - Pulmonary hypertension in older children: new approaches and therapies.
Abman SH. Abman SH. Paediatr Respir Rev. 2006;7 Suppl 1:S177-9. doi: 10.1016/j.prrv.2006.04.210. Epub 2006 Jun 5. Paediatr Respir Rev. 2006. PMID: 16798555 Review. No abstract available. - Emerging therapies for pulmonary arterial hypertension.
Ali O, Wharton J, Gibbs JS, Howard L, Wilkins MR. Ali O, et al. Expert Opin Investig Drugs. 2007 Jun;16(6):803-18. doi: 10.1517/13543784.16.6.803. Expert Opin Investig Drugs. 2007. PMID: 17501693 Review.
Cited by
- Remodelling and dysfunction of the sinus node in pulmonary arterial hypertension.
Logantha SJRJ, Yamanushi TT, Absi M, Temple IP, Kabuto H, Hirakawa E, Quigley G, Zhang X, Gurney AM, Hart G, Zhang H, Dobrzynski H, Boyett MR, Yanni J. Logantha SJRJ, et al. Philos Trans R Soc Lond B Biol Sci. 2023 Jun 19;378(1879):20220178. doi: 10.1098/rstb.2022.0178. Epub 2023 May 1. Philos Trans R Soc Lond B Biol Sci. 2023. PMID: 37122221 Free PMC article. - Reactive Oxygen and Nitrogen Species in the Development of Pulmonary Hypertension.
Fulton DJR, Li X, Bordan Z, Haigh S, Bentley A, Chen F, Barman SA. Fulton DJR, et al. Antioxidants (Basel). 2017 Jul 6;6(3):54. doi: 10.3390/antiox6030054. Antioxidants (Basel). 2017. PMID: 28684719 Free PMC article. Review. - Thrombin has biphasic effects on the nitric oxide-cGMP pathway in endothelial cells and contributes to experimental pulmonary hypertension.
Nickel KF, Laux V, Heumann R, von Degenfeld G. Nickel KF, et al. PLoS One. 2013 Jun 13;8(6):e63504. doi: 10.1371/journal.pone.0063504. Print 2013. PLoS One. 2013. PMID: 23785394 Free PMC article. - Hypoxia and dehydroepiandrosterone in old age: a mouse survival study.
Debonneuil EH, Quillard J, Baulieu EE. Debonneuil EH, et al. Respir Res. 2006 Dec 18;7(1):144. doi: 10.1186/1465-9921-7-144. Respir Res. 2006. PMID: 17176479 Free PMC article. - B-type natriuretic Peptide and the right heart.
Yap LB. Yap LB. Heart Fail Rev. 2004 Apr;9(2):99-105. doi: 10.1023/B:HREV.0000046364.68371.b0. Heart Fail Rev. 2004. PMID: 15516857 Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical